Kennedy has publicly backed wider access to peptides, casting restrictions as unnecessary barriers that may push patients to the grey market
Syed SK, Bui HH, Beavers LS, Farb TB, Ficorilli J, Chesterfield AK, et al
BPC-157 is just another peptide - a string of 15 amino acids that is selling like hot cakes
Patients currently using AOM tirzepatide may need to switch to AOM semaglutide to maintain insurance coverage of the medication, while those wishing to remain on tirzepatide may face higher out-of-pocket costs or coverage denials
Key Considerations: No federal approval exists for these peptides outside research settings Safety data in healthy populations is limited Product quality varies significantly between suppliers Medical supervision is recommended before use Final Thoughts on Recovery-Focused Peptides Effective recovery determines whether an athlete progresses or stagnates
Xenobiotica 53 (8-9), 559571